125 related articles for article (PubMed ID: 28459197)
1. Predictive and prognostic value of serum periostin in advanced non-small cell lung cancer patients receiving chemotherapy.
Zhang Y; Yuan D; Yao Y; Sun W; Shi Y; Su X
Tumour Biol; 2017 May; 39(5):1010428317698367. PubMed ID: 28459197
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic and prognostic value of serum periostin in patients with non-small cell lung cancer.
Xu CH; Wang W; Lin Y; Qian LH; Zhang XW; Wang QB; Yu LK
Oncotarget; 2017 Mar; 8(12):18746-18753. PubMed ID: 27816968
[TBL] [Abstract][Full Text] [Related]
3. High preoparative levels of serum periostin are associated with poor prognosis in patients with hepatocellular carcinoma after hepatectomy.
Lv Y; Wang W; Jia WD; Sun QK; Huang M; Zhou HC; Xia HH; Liu WB; Chen H; Sun SN; Xu GL
Eur J Surg Oncol; 2013 Oct; 39(10):1129-35. PubMed ID: 23916473
[TBL] [Abstract][Full Text] [Related]
4. Elevated serum periostin levels in patients with bone metastases from breast but not lung cancer.
Sasaki H; Yu CY; Dai M; Tam C; Loda M; Auclair D; Chen LB; Elias A
Breast Cancer Res Treat; 2003 Feb; 77(3):245-52. PubMed ID: 12602924
[TBL] [Abstract][Full Text] [Related]
5. Serum level of the periostin, a homologue of an insect cell adhesion molecule, as a prognostic marker in nonsmall cell lung carcinomas.
Sasaki H; Dai M; Auclair D; Fukai I; Kiriyama M; Yamakawa Y; Fujii Y; Chen LB
Cancer; 2001 Aug; 92(4):843-8. PubMed ID: 11550156
[TBL] [Abstract][Full Text] [Related]
6. Extracellular cytochrome c as a biomarker for monitoring therapeutic efficacy and prognosis of non-small cell lung cancer patients.
Javid J; Mir R; Julka PK; Ray PC; Saxena A
Tumour Biol; 2015 Jun; 36(6):4253-60. PubMed ID: 25578497
[TBL] [Abstract][Full Text] [Related]
7. Study of pretreatment serum levels of HER-2/neu oncoprotein as a prognostic and predictive factor in patients with advanced nonsmall cell lung carcinoma.
Ardizzoni A; Cafferata MA; Paganuzzi M; Filiberti R; Marroni P; Neri M; Fontana V; Nicoló G; Perdelli L; Stampino CG; Rosso R; Puntoni R
Cancer; 2001 Oct; 92(7):1896-904. PubMed ID: 11745263
[TBL] [Abstract][Full Text] [Related]
8. High serum levels of periostin are associated with a poor survival in breast cancer.
Rachner TD; Göbel A; Hoffmann O; Erdmann K; Kasimir-Bauer S; Breining D; Kimmig R; Hofbauer LC; Bittner AK
Breast Cancer Res Treat; 2020 Apr; 180(2):515-524. PubMed ID: 32040688
[TBL] [Abstract][Full Text] [Related]
9. A laboratory prognostic index model for patients with advanced non-small cell lung cancer.
Ulas A; Turkoz FP; Silay K; Tokluoglu S; Avci N; Oksuzoglu B; Alkis N
PLoS One; 2014; 9(12):e114471. PubMed ID: 25474743
[TBL] [Abstract][Full Text] [Related]
10. The relationship between Glasgow Prognostic Score and serum tumor markers in patients with advanced non-small cell lung cancer.
Jiang AG; Chen HL; Lu HY
BMC Cancer; 2015 May; 15():386. PubMed ID: 25956656
[TBL] [Abstract][Full Text] [Related]
11. Baseline and decline of serum ADAM28 during chemotherapy of advanced non-small cell lung cancer: a probable predictive and prognostic factor.
Lv YL; Yuan DM; Wang QB; Zhan P; Luo L; Lv TF; Liu HB; Li YF; Wen J; Song Y
Med Oncol; 2012 Dec; 29(4):2633-9. PubMed ID: 22354764
[TBL] [Abstract][Full Text] [Related]
12. Predictive and prognostic significance of circulating endothelial cells in advanced non-small cell lung cancer patients.
Yuan DM; Zhang Q; Lv YL; Ma XQ; Zhang Y; Liu HB; Song Y
Tumour Biol; 2015 Nov; 36(11):9031-7. PubMed ID: 26084612
[TBL] [Abstract][Full Text] [Related]
13. Periostin Expression in Non-Small Cell Lung Cancer: Clinical Significance.
Murakami D; Takamori S; Kawahara A; Mitsuoka M; Kashihara M; Yoshiyama K; Matsumoto R; Yokoyama S; Fujimoto K; Kawaguchi A; Izuhara K; Akagi Y
Kurume Med J; 2018 Feb; 64(1.2):13-20. PubMed ID: 29176296
[TBL] [Abstract][Full Text] [Related]
14. Clinical and prognostic importance of XIAP and USP8 in advanced stages of non-small cell lung cancer.
Baykara M; Yaman M; Buyukberber S; Tufan G; Demirci U; Benekli M; Coskun U; Ozet A; Umit Bagriacik E
J BUON; 2013; 18(4):921-7. PubMed ID: 24344018
[TBL] [Abstract][Full Text] [Related]
15. Expression of periostin in the serum of NSCLC and its function on proliferation and migration of human lung adenocarcinoma cell line (A549) in vitro.
Hong L; Sun H; Lv X; Yang D; Zhang J; Shi Y
Mol Biol Rep; 2010 Jun; 37(5):2285-93. PubMed ID: 19688273
[TBL] [Abstract][Full Text] [Related]
16. Circulating levels of periostin may help identify patients with more aggressive colorectal cancer.
Ben QW; Zhao Z; Ge SF; Zhou J; Yuan F; Yuan YZ
Int J Oncol; 2009 Mar; 34(3):821-8. PubMed ID: 19212687
[TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of C-reactive protein and smoking in patients with advanced non-small cell lung cancer treated with first-line palliative chemotherapy.
Koch A; Fohlin H; Sörenson S
J Thorac Oncol; 2009 Mar; 4(3):326-32. PubMed ID: 19155996
[TBL] [Abstract][Full Text] [Related]
18. Circulating interleukin-6 level is a prognostic marker for survival in advanced nonsmall cell lung cancer patients treated with chemotherapy.
Chang CH; Hsiao CF; Yeh YM; Chang GC; Tsai YH; Chen YM; Huang MS; Chen HL; Li YJ; Yang PC; Chen CJ; Hsiung CA; Su WC
Int J Cancer; 2013 May; 132(9):1977-85. PubMed ID: 23034889
[TBL] [Abstract][Full Text] [Related]
19. Serum vascular endothelial growth factor (VEGF) and bcl-2 levels in advanced stage non-small cell lung cancer.
Tas F; Duranyildiz D; Oguz H; Camlica H; Yasasever V; Topuz E
Cancer Invest; 2006 Oct; 24(6):576-80. PubMed ID: 16982461
[TBL] [Abstract][Full Text] [Related]
20. Circulating DNA is a useful prognostic factor in patients with advanced non-small cell lung cancer.
Sirera R; Bremnes RM; Cabrera A; Jantus-Lewintre E; Sanmartín E; Blasco A; Del Pozo N; Rosell R; Guijarro R; Galbis J; Sánchez JJ; Camps C
J Thorac Oncol; 2011 Feb; 6(2):286-90. PubMed ID: 21252717
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
